scholarly journals Preliminary validation of an exercise program suitable for pregnant women with abnormal glucose metabolism: inhibitory effects of Tai Chi Yuttari-exercise on plasma glucose elevation

2016 ◽  
Vol 28 (12) ◽  
pp. 3411-3415 ◽  
Author(s):  
Sachina Yamamoto ◽  
Kyoko Kagawa ◽  
Naohi Hori ◽  
Yoshiteru Akezaki ◽  
Kohei Mori ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Pregnant Women ◽  
Plasma Glucose ◽  
Tai Chi ◽  
Exercise Program ◽  
Inhibitory Effects ◽  
Abnormal Glucose Metabolism ◽  
Preliminary Validation

scholarly journals Maternal Pre-Pregnancy Obesity Combined With Abnormal Glucose Metabolism Further Increases Adverse Pregnancy Outcomes in Chinese Pregnant Women

2022 ◽  
Vol 12 ◽  
Author(s):  
Mei-Fang Li ◽  
Jiang-Feng Ke ◽  
Li Ma ◽  
Jun-Wei Wang ◽  
Zhi-Hui Zhang ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Pregnant Women ◽  
Pregnancy Outcomes ◽  
Perinatal Outcomes ◽  
Adverse Pregnancy Outcomes ◽  
Control Group ◽  
Abnormal Glucose Metabolism ◽  
Induced Hypertension ◽  
Adverse Perinatal Outcomes ◽  
Adverse Pregnancy

AimsOur aim was to evaluate the separate and combined effects of maternal pre-pregnancy obesity and gestational abnormal glucose metabolism (GAGM) on adverse perinatal outcomes.MethodsA total of 2,796 Chinese pregnant women with singleton delivery were studied, including 257 women with pre-pregnancy obesity alone, 604 with GAGM alone, 190 with both two conditions, and 1,745 with neither pre-pregnancy obesity nor GAGM as control group. The prevalence and risks of adverse pregnancy outcomes were compared among the four groups.ResultsCompared with the normal group, pregnant women with maternal pre-pregnancy obesity alone, GAGM alone, and both two conditions faced significantly increased risks of pregnancy-induced hypertension (PIH) (odds ratio (OR) 4.045, [95% confidence interval (CI) 2.286–7.156]; 1.993 [1.171–3.393]; 8.495 [4.982–14.485]), preeclampsia (2.649 [1.224–5.735]; 2.129 [1.128–4.017]; 4.643 [2.217–9.727]), cesarean delivery (1.589 [1.212–2.083]; 1.328 [1.095–1.611]; 2.627 [1.908–3.617]), preterm delivery (1.899 [1.205–2.993]; 1.358 [0.937–1.968]; 2.301 [1.423–3.720]), macrosomia (2.449 [1.517–3.954]; 1.966 [1.356–2.851]; 4.576 [2.895–7.233]), and total adverse maternal outcomes (1.762 [1.331–2.332]; 1.365 [1.122–1.659]; 3.228 [2.272–4.587]) and neonatal outcomes (1.951 [1.361–2.798]; 1.547 [1.170–2.046]; 3.557 [2.471–5.122]). Most importantly, there were no obvious risk differences in adverse pregnancy outcomes between maternal pre-pregnancy obesity and GAGM group except PIH, but pregnant women with both obesity and GAGM exhibited dramatically higher risks of adverse pregnancy outcomes than those with each condition alone.ConclusionsMaternal pre-pregnancy obesity and GAGM were independently associated with increased risks of adverse pregnancy outcomes. The combination of pre-pregnancy obesity and GAGM further worsens adverse pregnancy outcomes compared with each condition alone.

scholarly journals A community-based survey for different abnormal glucose metabolism among pregnant women in a random household study (SAUDI-DM)

BMJ Open ◽  
2014 ◽  
Vol 4 (8) ◽  
pp. e005906-e005906 ◽  
Author(s):  
K. Al-Rubeaan ◽  
H. A. Al-Manaa ◽  
T. A. Khoja ◽  
A. M. Youssef ◽  
A. H. Al-Sharqawi ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Pregnant Women ◽  
Community Based ◽  
Abnormal Glucose Metabolism

scholarly journals Application of CEEMD noise reduction algorithm in ultrasound imaging in evaluating fetuses with abnormal glucose metabolism in late pregnancy

2021 ◽  
Vol 37 (6-WIT) ◽  
Author(s):  
Junfeng Huang ◽  
Cuiting Wang ◽  
Xianxia Li ◽  
Yuqin Jing
Keyword(s):  
Glucose Metabolism ◽  
Pregnant Women ◽  
Pregnancy Outcomes ◽  
Color Doppler ◽  
Good Prognosis ◽  
Adverse Outcomes ◽  
Family History Of Diabetes ◽  
Abnormal Glucose Metabolism ◽  
Prognosis Group ◽  
Good Prognosis Group

Objectives: To explore the predictive effect of abnormal glucose metabolism and fetal hemodynamic parameters on adverse pregnancy outcome. Methods: One hundred and nine pregnant women with abnormal glucose metabolism during pregnancy from June 2016 to October 2018 were selected and divided into poor prognosis group (34 cases) and good prognosis group (75 cases). The hemodynamic parameters of fetal cerebral artery (MCA), umbilical artery (UA) and uterine artery of pregnancy (UT-A), including peak systolic velocity (s / D), resistance index (RI) and plasticity index (PI), were measured by color Doppler ultrasound. The receiver operating characteristic (ROC) curve of adverse pregnancy outcomes was drawn and the best threshold index was determined. Results: MCA-PI poor prognosis group, MCA-RI, RI ratio (MCA/UA) are lower than the good prognosis group, Ut-A-PI is higher than the good prognosis group (P<0.05,). ROC curve analysis results show that when the MCA-PI 1.56, the sensitivity of the predicted adverse outcomes of pregnancy, the highest specificity<, was 91.18%, 80.00%, respectively. Logistic regression analysis of risk factors shows poor pregnancy outcomes include: pregnant women, older age, body mass index ≥24.0kg/m2 and a family history of diabetes. Protective factors include exercise during pregnancy, MCA-PI≥1.56, MCA-RI≥0.63 and RI The ratio (MCA/UA) ≥0.84. Conclusion: Color Doppler ultrasound measured MCA-PI<1.56 the most important indicators of poor pregnancy outcomes as abnormal glucose metabolism during pregnancy and predict the exact cutoff. Pregnant women, older age, body mass index ≥24.0kg/m2 and a family history of diabetes and abnormal glucose metabolism during pregnancy risk factors for adverse outcomes of pregnancy. doi: https://doi.org/10.12669/pjms.37.6-WIT.4844 How to cite this:Huang J, Wang C, Li X, Jing Y. Application of CEEMD noise reduction algorithm in ultrasound imaging in evaluating fetuses with abnormal glucose metabolism in late pregnancy. Pak J Med Sci. 2021;37(6):1590-1594. doi: https://doi.org/10.12669/pjms.37.6-WIT.4844 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile

2018 ◽  
Vol 89 (6) ◽  
pp. 757-764 ◽  
Author(s):  
Anastasios Serbis ◽  
Vasileios Giapros ◽  
Anna Challa ◽  
Nikolaos Chaliasos ◽  
Ekaterini Siomou
Keyword(s):  
Glucose Metabolism ◽  
Plasma Glucose ◽  
Abnormal Glucose Metabolism ◽  
Obese Youth ◽  
Inflammatory Profile

P6517Three-year clinical outcome of patients with abnormal glucose metabolism treated with contemporary drug-eluting stents

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
E H Ploumen ◽  
R A Buiten ◽  
M M Kok ◽  
P Zocca ◽  
C J M Doggen ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Glucose Metabolism ◽  
Plasma Glucose ◽  
Fasting Plasma Glucose ◽  
Drug Eluting Stents ◽  
Target Vessel ◽  
Abnormal Glucose Metabolism ◽  
Fasting Plasma ◽  
Drug Eluting ◽  
Periprocedural Myocardial Infarction

Abstract Background/Introduction Patients with coronary artery disease that have an abnormal glucose metabolism are known to have more extensive and complex atherosclerotic coronary disease. In patients without previously known diabetes, abnormal glucose metabolism was shown to be independently associated with an up to four-fold higher event risk during the first year after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Purpose To examine the 3-year clinical outcome after stenting with contemporary DES in patients with abnormal glucose metabolism, either detected by oral glucose tolerance testing (OGTT) or by glycated haemoglobin A1c (HbA1c) and fasting plasma glucose. Methods The present analysis is a local substudy of the BIO-RESORT randomised trial. OGTT and HbA1c with fasting plasma glucose were prospectively assessed in 988 trial participants without previously known diabetes. The main clinical endpoint was target vessel failure, a composite of cardiac death, target vessel-related myocardial infarction or target vessel revascularisation at 3-years. Results In one out of three study participants (330/988), abnormal glucose metabolism was detected by either OGTT or HbA1c and fasting plasma glucose. Three-year follow up was available in 99.8% of these patients. The rate of target vessel failure was significantly higher in patients with abnormal glucose metabolism versus normoglycaemic patients (8.8% vs. 5.5%, p=0.044; Figure). This difference was driven by the incidence of periprocedural myocardial infarction that was higher in patients with abnormal glucose metabolism than in patients with normoglycaemia (4.5% vs. 1.4%, p=0.002). Target vessel failure at 3-years Conclusion Abnormal glucose metabolism was associated with a significantly higher risk of target vessel failure at 3-years; this difference was driven by higher rates of periprocedural myocardial infarction. Acknowledgement/Funding The present substudy received no additional funding. The BIO-RESORT trial was equally funded by Biotronik, Boston Scientific, and Medtronic.

Sign in / Sign up

Export Citation Format

Share Document